Dr Polly Carmichael, director of GIDS, said: “The results show patient experience on the blocker is positive overall and there were no unexpected adverse events, but that more research is needed around this complex issue.”
Presumably the stunted growth, reduced bone mass, failure to improve psychological function, headaches, menopausal symptoms, fatigue, inevitable progression to XS hormones, infertility and lifelong medicalisation including increased risks of suicidality after transition we're all expected adverse events then.
Zero measurable benefit, weighed against a huge list of expected and measurable harms. That's literally the conclusion.
I remember a few years ago a few of us wondering whether Polly Carmichael might have been on the verge of regretting what she was doing. She's definitely w£ighed up the odds and gone all in since.